Neurogene Inc. (NGNE)

NASDAQ: NGNE · Real-Time Price · USD

17.01

-1.73 (-9.23%)

At close: May 30, 2025, 4:00 PM

17.86

+0.85 (5.00%)

After-hours: May 30, 2025, 5:37 PM EDT

Neurogene Employees

Neurogene had 107 employees as of December 31, 2024. The number of employees increased by 16 or 17.58% compared to the previous year.

Employees

107

Change (1Y)

16

Growth (1Y)

17.58%

Revenue / Employee

$8,645

Profits / Employee

-$755,794

Market Cap

242.60M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	107	16	17.58%
Dec 31, 2023	91	9	10.98%
Dec 31, 2022	82	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Abbott Laboratories	114,000
AstraZeneca	94,300
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000
AbbVie	55,000

Employee Rankings

NGNE News

14 days ago - Neurogene Announces Evidence-Based Monitoring and Treatment Intended to Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV - Business Wire
21 days ago - Neurogene Reports First Quarter 2025 Financial Results and Highlights Recent Updates - Business Wire
22 days ago - Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
4 weeks ago - Neurogene Announces Upcoming Oral Presentation on Monitoring and Treatment to Reverse Rare Complication of High Dose Gene Therapy at the ASGCT Annual Meeting - Business Wire
2 months ago - Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome - Business Wire
2 months ago - Neurogene Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Updates - Business Wire
3 months ago - Neurogene to Participate in Upcoming Conferences - Business Wire
6 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Neurogene Inc. (NGNE) And Encourages Shareholders to Reach Out - Accesswire